Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Haziran 2025 | 0 |
| Temmuz 2025 | 0 |
| Ağustos 2025 | 0 |
| Eylül 2025 | 0 |
| Ekim 2025 | 0 |
| Kasım 2025 | 0 |
| Aralık 2025 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Combined-metabolic-activators-improve-cognitive-functions-in-Alzheimers-disease-patients-a-randomised-doubleblinded-placebocontrolled-phaseII-trialTranslational-Neurodegeneration.pdf | 4 |
